Stocktoria
ARROWHEAD PHARMACEUTICALS, INC. ARWR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1993-12-14
ARROWHEAD PHARMACEUTICALS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 11.9% | -16927.1% | -85.2% | -73.4% | -107.8% |
| Net margin | -0.2% | -16882.4% | -85.3% | -72.4% | -101.9% |
| FCF margin | 18.9% | -17018.3% | -137.3% | -77.7% | 106.8% |
| Return on assets | -0.1% | -52.6% | -26.8% | -25.4% | -19.8% |
| Return on equity | -0.3% | -313.8% | -71.5% | -42.1% | -34.5% |
| Current ratio | 4.86 | 6.74 | 3.95 | 2.92 | 2.62 |
| Revenue growth | 23258.2% | -98.5% | -1.0% | 75.9% | 57.2% |
Source: SEC EDGAR filings · CIK 0000879407 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.